By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Shares of Sequenom rose 62 percent during the month of February — boosted by the launch of a couple of molecular diagnostic tests — to lead all of the 33 stocks in the GenomeWeb Daily News Index.

The San Diego-based firm was one of four stocks in the Index that gained more than 20 percent for the month. The others included Affymetrix (+38 percent), Millipore (+37 percent), and Caliper Life Sciences (+23 percent).

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.